1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ROYALTY PHARMA PLC - ORDINARY SHARES - CLASS A
Royalty Pharma plc - Ordinary Shares - Class A XNAS: RPRX

Royalty Pharma plc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Strong Performer, Under Radar
about

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products...

Read More
35.67 -0.39 (-1.08%)
48.32% Gain from 52W Low
902.1K
XNAS Volume

XNAS 28 Aug, 2025 2:39 PM (EDT)

Watchlist

Portfolio

Alert

Share
Acquisition
Royalty Pharma to acquire 7% royalty in Amgen's lung cancer drug Imdelltra for $950 million See details
Durability score
High Financial Strength
55.6 / 100
Valuation Score
Affordable Valuation
50.5 / 100
Momentum Score
Technically Neutral
49.8 / 100
Strong Performer, Under Radar These stocks are with good quality scores and with strong financials. They are affordably priced stocks and can give good returns View Similar Embed DVM
Analyst Price Target
43
1Yr Price target upside is 21%
8 analysts

6

S

6

W

3

O

1

T

SWOT Analysis

Royalty Pharma plc - Ordin... Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..